SCHEMBL4339614

SCHEMBL4339614

CCOC(=O)C(Cc1cccc(OCC(O)COc2ccc(C(C)(C)C)cc2)c1)OC(C)C

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.43
USP2 O75604 1/20 0.43
SMN1; SMN2 Q16637 1/20 0.43
LMNA P02545 3/20 0.41
HSD17B10 Q99714 1/20 0.41
MAPT P10636 3/20 0.40
MAPK1 P28482 2/20 0.40
L3MBTL1 Q9Y468 2/20 0.40
TSHR P16473 2/20 0.40
MEN1 O00255 2/20 0.40
KMT2A Q03164 2/20 0.40
TDP1 Q9NUW8 1/20 0.40
PPARG P37231 2/20 0.40
PPARA Q07869 2/20 0.40
PPARD Q03181 1/20 0.40
HTT P42858 1/20 0.39
KDM4E B2RXH2 1/20 0.39
NR4A1 P22736 1/20 0.38
NR4A2 P43354 1/20 0.38
NR4A3 Q92570 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4340629 0.91 PPARD (0.42) MAPTMAPK1L3MBTL1TSHRTDP1
SCHEMBL4339408 0.91 KMT2A (0.40) ALDH1A1USP2SMN1; SMN2LMNAMAPT
SCHEMBL4337925 0.89 PPARG (0.50) ALDH1A1LMNAMAPTTSHRMEN1
SCHEMBL6650392 0.81 MEN1 (0.37) MAPK1L3MBTL1TSHRMEN1KMT2A
SCHEMBL4329088 0.80 KMT2A (0.41) ALDH1A1SMN1; SMN2LMNAMAPK1L3MBTL1
SCHEMBL4329084 0.80 KMT2A (0.41) ALDH1A1SMN1; SMN2LMNAMAPK1L3MBTL1
SCHEMBL4333168 0.80 KMT2A (0.41) ALDH1A1SMN1; SMN2LMNAMAPK1L3MBTL1
SCHEMBL4348598 0.80 PPARG (0.49) ALDH1A1LMNAMEN1KMT2APPARG
SCHEMBL4346891 0.80 PPARG (0.51) PPARGPPARAPPARD
SCHEMBL4340812 0.80 PPARG (0.43) PPARGPPARAPPARD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7544835-B2 Carboxylic acid derivative and salt thereof EISAI R&D MANAGEMENT CO., LTD. (JP) 2009-06-09 US disclosed
US-20040102634-A1 Carboxylic acid derivative and salt thereof EISAI R&D MANAGEMENT CO., LTD. (JP) 2004-05-27 US disclosed
EP-1380562-A1 CARBOXYLIC ACID DERIVATIVE AND SALT THEREOF Eisai Co., Ltd. (JP) 2004-01-14 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040102634-A1 Carboxylic acid derivative and salt thereof GPR119, IRS1, SLC5A1 ALDH1A1 844/4885USP2 4526/4885SMN1; SMN2 3054/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.